Symbiotec Pharmalab shares listed at ₹988 on the NSE, matching the IPO issue price and giving investors no listing gain. The ₹1,757-crore IPO was subscribed 71.26 times, led by QIB demand of 172.03 times. The issue comprised a ₹150 crore fresh issue and ₹1,607-crore OFS.